<!DOCTYPE html>
<html>

<head>
  <meta charset="utf-8" />
  <title>HLAMatchmaker</title>

  <!--SEO Meta Tags-->
  <meta name="description" content="HLAMatchmaker" />
  <meta name="keywords" content="hla matchmaker epitopes" />
  <meta name="author" content="rene duquesnoy reneduquesnoy" />

  <!--Mobile Specific Meta Tag-->
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no">

  <!--Favicon-->
  <link rel="shortcut icon" href="favicon.png" type="image/x-icon">

  <!-- Page Specific Styles -->
  <link href="css/style.css" rel="stylesheet">
  
  <!-- Page Specific Color Styles -->
  <link class="color-scheme" href="css/colors/blue.css" rel="stylesheet" media="screen">

  <!--Modernizr-->
  <script src="js/libs/modernizr.custom.js"></script>

  <!--Modernizr extention-->
  <script src="js/libs/detectizr.min.js"></script>
  <script src="/vendor.js"></script>
  <script src="/app.js"></script>
  <script src="https://apis.google.com/js/platform.js" async defer></script>
  <meta name="google-signin-client_id" content="352143239627-9d38hjeu01jdp2vin9icvj5km8i4p134.apps.googleusercontent.com">
</head>

<body class="parallax">
  <span class="scroll-up scrollTop-btn"><i class="fa fa-chevron-up"></i></span>

  <div class="wrapper">
    <div class="top-bar">
      <div class="container">
        <ul class="list-inline adress-bar">
          <li>
            <i class="fa fa-envelope"></i>
            <a href="mailto:duquesnoyr@upmc.edu">duquesnoyr@upmc.edu</a>
          </li>
        </ul>
      </div>
    </div>

    <!-- Navbar -->
        <header class="header no-animation">
      <div class="container">
        <nav class="navbar navbar-default" role="navigation">
   <!-- <header class="header header-animated">
      <div class="container">
        <nav class="navbar navbar-default" role="navigation">
          <div class="navbar-header">
            <a class="logo" href="index.html">
              <img src="img/logo-dark.png" data-logo-default="img/logo-light.png" data-logo-alt="img/logo-dark.png" alt="HLAMatchmaker" />
            </a>
          </div>-->

          <!-- Collect the nav links, forms, and other content for toggling -->
          <div class="collapse navbar-collapse" id="navbarMain">
            <ul class="nav navbar-nav navbar-right">
    	      <li>
                <img id="me" width='36' src="/img/hla/noimg.gif">
              </li>
              <li id="login">
                <div class="g-signin2" data-onsuccess="googleSignIn"></div>              
              </li>
            </ul>

            <ul class="nav navbar-nav collapsed-color">
              <li>
                <a href="index.html">Home</a>
              </li>
              <li>
                <a href="what.html">What</a>
              </li>
              <li class="active">
                <a href="#" class="scroll-up">Publications</a>
              </li>
              <li>
                <a href="education.html">Education</a>
              </li>
              <li>
                <a href="conferences.html">Conferences</a>
              </li>
              <li>
                <a href="downloads.html">Downloads</a>
              </li>
              <li>
                <a href="contact.html">Contact Us</a>
              </li>
            </ul>
          </div>
          <!-- .navbar-collapse -->
        </nav>
      </div>
    </header>
    <!-- ***** HEADER END ***** -->

    <main class="content main-animation">

      <!-- ***** ICONS ***** -->
      <section class="icons-block margin-top-2x" id="publications">
        <div class="container">
          <div class="text-center">
            <h2 class="block-header"><br>
              <span>Duquesnoy Publications On HLA Epitopes</span>
            </h2></br>
            <div >
                <table class="table">
                    <tr> 
                        <td><a href="/pdfs/rene/01txproc2001.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">1. Duquesnoy, RJ: HLAMatchmaker: A Molecularly Based Donor-Selection Algorithm for Highly Allosensitized Patients. <i>Transplantation Proc. 33: 493-497, 2001 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/02PartIHI2002.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">2. Duquesnoy, RJ: HLAMatchmaker: A Molecularly Based Algorithm For Histocompatibility Determination I Description of the Algorithm, <i>Human Immunology 63: 339-352, 2002 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/03hi2002.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">3. Duquesnoy, RJ and Marrari, M: HLAMatchmaker: A Molecularly Based Algorithm For Histocompatibility Determination II Verification of the Algorithm and Determination of the Relative Immunogenicity of Amino Acid Triplet-Defined Epitopes, <i>Human Immunology 63: 353-263, 2002 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U42002ASHIquarterly.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">4. Duquesnoy, RJ, HLAMatchmaker: A Molecularly Based Algorithm For Histocompatibility Determination. <i>ASHI Quarterly, 2002: p. 60-62 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/05tx752003.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">5. Duquesnoy, RJ , Takemoto S, de LangeP, Doxiadis IIN, Schreuder GMTh , Persijn, G and Claas FJH: HLAMatchmaker: A Molecularly Based Algorithm For Histocompatibility Determination III Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. <i>Transplantation 75: 884-889, 2003 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/06tx2003.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">6. Duquesnoy, RJ, Howe J, and Takemoto, S: HLAMatchmaker: A Molecularly Based Algorithm For Histocompatibility Determination. IV An Alternative Strategy to Increase the Number of Compatible Donors for Highly Sensitized Patients, <i>Transplantation 75: 889-897, 2003 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/07txint2004.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">7. Duquesnoy, RJ, Witvliet M, Doxiadis I IN, de Fijter H and Claas FHJ: HLAMatchmaker-Based Strategy to Identify Acceptable HLA Class I Mismatches for Highly Sensitized Kidney Transplant Candidates, <i>Transplant International 7: 31-38, 2004 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/08txim2005.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">8. Adeyi OE, Girnita A, Howe J, Marrari M, Awadalla Y, Askar M, Martell J, Zeevi A, Shapiro R, Nalesnik M, Rhandawa P, Demetris AJ, and Duquesnoy RJ: Serum Analysis After Kidney Transplant Nephrectomy Reveals Restricted Antibody Specificity Patterns Against Structural HLA Class I Mismatches, <i>Transplant Immunology 14: 53-62, 2005 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/09tx2005.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">9. Duquesnoy, RJ and Claas, FHJ: Is the Application of HLAMatchmaker Relevant in Kidney Transplantation? (Letter to the Editor), <i>Transplantation 79: 250-251, 2005 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/10hi2005.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">10. Duquesnoy RJ, Mulder A, Askar M, Fernandez-Vina M,  and Claas FHJ: HLAMatchmaker-Based Analysis of Human Monoclonal Antibody Reactivity Demonstrates the Importance of an Additional Contact Site for Specific Recognition of Triplet-Defined Epitopes, <i>Human Immunology 66: 749-761, 2005 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/11imres2006.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">11. Zeevi A, Girnita A, and Duquesnoy R: HLA antibody analysis: sensitivity, specificity and clinical significance in solid organ transplantation. <i>Immunol. Res. 36:255-64, 2006 </i></td>
                    </tr>
                    <tr>
                        <td><br></td>
                        <td align="left">12. Duquesnoy RJ: The HLA system and histocompatibility testing for organ transplantation. <i>In Pediatric Transplantation (Eds. Fine R, Webber S, Harmon W, Kelly D and Olthoff K) 2nd Edit (Blackwell Publishing, NY) In Press, 2006</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/13hi2006.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">13. Duquesnoy RJ: A structurally based approach to determine HLA compatibility at the humoral immune level. <i>Human immunology 67: 847-862, 2006</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/14ta2007.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">14. Duquesnoy, RJ and Claas FHJ: Progress Report of 14th International Histocompatibility Workshop Project on the Structural Basis of HLA Compatibility, <i>Tissue Antigens 69 (Suppl. 1): 1-5, 2007</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/15hi2007.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">15. Duquesnoy, RJ and Askar, M: HLAMatchmaker: A Molecularly Based Algorithm for Histocompatibility Determination. V. Eplet Matching for HLA-DR, HLA-DQ and HLA-DP, <i>Human immunology 68: 12-25, 2007</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/16pedtx2007.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">16. Duquesnoy, RJ: “Match and Treat”, An Effective Strategy for Transplanting Highly Sensitized Pediatric Transplant Candidates? (Invited Editorial), <i>Pediatric Transplantation 11: 3-4, 2007</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/17tr2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">17. Duquesnoy, RJ : Structural Epitope Matching for HLA Alloimmunized Thrombocytopenic Patients: A New Strategy to Provide More Effective Platelet Transfusion Support? <i>Transfusion 48: 221-227, 2008</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/18txim2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">18. Duquesnoy RJ, Awadalla Y, Lomago J, Jelinek L, Howe J, Zern D, Hunter B, Martell J, Girnita A and A Zeevi: Retransplant Candidates Have Donor-Specific Antibodies that React with Structurally Defined HLA-DR,DQ,DP Epitopes. <i>Transplant Immunology 18: 352-360, 2008</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/19ashi2007.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">19. Duquesnoy, RJ : Update on HLAMatchmaker: a Molecularly Based Algorithm for Histocompatibility Determination at the Epitope Level, <i>EFI Newsletter, Fall 2007 and ASHI Quarterly 2007: p.74-79</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/20stemcell2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">20. Duquesnoy RJ, Spellman S, Haagenson M, Wang T, Horowitz M and Oudshoorn M: HLAMatchmaker-Defined Triplet Matching Is Not Associated with Better Survival Rates of Patients with Class I HLA Allele Mismatched Hematopoietic Cell Transplants from Unrelated Donors. <i>Biol. Blood & Marrow Transplantation 14:1064-1071, 2008</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/21tx2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">21. Duquesnoy RJ: HLA Class II Antibodies and Transplant Outcome (Invited Analysis and Commentary), <i>Transplantation 86:638-640, 2008</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/22copim2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">22. Duquesnoy, RJ: Clinical Usefulness of HLAMatchmaker in HLA Epitope Matching for Organ Transplantation, <i>Curr Opinion Immunol. (FJH Claas and RJ Duquesnoy, Eds), 20:1-8 , 2008</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/23mica2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">23. Duquesnoy RJ, Mostecki J, Hariharan J, and Balasz I: A Structurally Based Epitope Analysis of MICA Antibody Specificity Patterns. <i>Human Immunol. 69: 826-832, 2008</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/24dr22009.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">24. Marrari, M and Duquesnoy, RJ: Why can Sensitization by a HLA-DR2 Mismatch lead to Antibodies that react also with HLA-DR1? <i>Human Immunol. 70: 403-9, 2009</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/25terep12009.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">25. Duquesnoy RJ and Marrari M: Correlations between Terasaki’s HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A,B and -C antigens, <i>Tissue Antigens 74: 117-133, 2009</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/26terep22009.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">26. Marrari M and Duquesnoy, RJ: Correlations between Terasaki’s HLA class II epitopes and HLAMatchmaker-defined eplets on HLADR and DQ antigens, <i>Tissue Antigens 74: 134-146, 2009</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/27coptx2009.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">27. Duquesnoy RJ and Marrari M: HLAMatchmaker-Based Definition of Structural HLA Epitopes Detected by Alloantibodies, <i>Curr Opinion in Transplantation 14:403-9, 2009</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/28allonx2010.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">28. Marrari M and Duquesnoy RJ: Detection of donor-specific HLA antibodies in kidney transplant patients before and after removal of a rejected kidney transplant, <i>Transplant Immunology, 22: 105-109, 2010</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/29b442010.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">29. Lomago J, Jelenik l, Zern D, Howe I, Martell J, Zeevi A and Duquesnoy RJ: How did a Patient Who Types for HLA-B*4403 Develop Antibodies that React with HLA-B*4402? <i>Human immunology, 71: 176-178, 2010</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/30pairs2010.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">30. Marrari M, Mostecki J, Mulder A, Claas F, Balazs and Duquesnoy RJ: Human Monoclonal Antibody Reactivity with HLA Class I Epitopes Defined by Pairs of Human Monoclonal Antibody Reactivity with HLA Class I Epitopes Defined by Pairs of Mismatched Eplets and Self Eplets, <i>Transplantation 90: 1468-72, 2010</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/31hlac2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">31. Duquesnoy RJ and Marrari M: Detection of Antibodies against HLA-C Epitopes in Patients with Rejected Kidney Transplants, <i>Transplant Immunol 24: 164-71, 2011</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/32revta2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">32. Duquesnoy RJ: Antibody-Reactive Epitope Determination with HLAMatchmaker and Its Application in Transplantation (Invited review), <i>Tissue Antigens 77: 525-534, 2011</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U33_sns_IJ_Immgen_2012.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">33. Duquesnoy RJ: The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity (Invited Article), <i>Int J Immunogenetics, 39:1-9, 2011</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U34_Conca_HI_2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">34. Marrari M, Conca R, Praticò-Barbato L, Amoroso A and Duquesnoy: RJ: Brief Report: Why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13? <i>Transplant Immunology, 25: 217-220, 2011</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U35_Hum_alloimmunity_Frontiers_publication.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">35. Duquesnoy RJ: Humoral Alloimmunity in Transplantation: Relevance of HLA Epitope Antigenicity and Immunogenicity, <i>Frontiers in Transplantation and Alloimmunity, 2: 59, 2011 published online</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U36_Zeevi_ped_case_2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">36. Zeevi A, Marrari M, Feingold B, Webber S and Duquesnoy RJ: HLA epitope analysis to assess complement and non-complement binding donor specific antibody repertoire in a pediatric heart transplant recipient, <i>Hum Immunol, 73: 48-51, 2012</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U37_struct_ms_HI_2012.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">37. Duquesnoy RJ, Marrari M, Mulder A, Claas FJH, Mostecki J and Balazs I: Structural Aspects of HLA Class I Epitopes Detected by Human Monoclonal Antibodies, <i>Human Immunol. 73: 267-277, 2012</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U38_16th__wrkshp_report_IJI_2012.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">38. Duquesnoy RJ, Marrari M, da M. Sousa LCD, de M. Barroso JRP, de SE Aita KM, da Silva AS and do Monte SJH : 16th IHIW: a website for the antibody-defined HLA epitope registry. <i>Int J. Immunogenetics, 40: 54-59, 2013</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U39_C1q_epitope_publ_in_HumIm.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">39. Duquesnoy RJ, Marrari M, Jelenik L, Zeevi A, Claas FHJ and Mulder A: Structural Aspects of HLA Class I Epitopes Reacting with Human Monoclonal Antibodies in Ig-Binding, C1q-Binding and Lymphocytotoxicity Assays, <i>Human Immunology, 74:1271-1279, 2013</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U40_RJD_Ep_matching_review_Tx_Imm_June_2014.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">40. Duquesnoy RJ: HLA Epitope Based Matching for Transplantation. <i>(Editorial) Transplant Immunology, 31:1-6, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U41_new_ABC_eplet_design_TA_June_2014.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">41. Duquesnoy RJ: Update of the HLA Class I Eplet Database in the Website Based Registry of Antibody-Defined HLA Epitopes, <i>Tissue Antigens, 83:382-390, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U42_First_report_antibody-verified_ABC_epitopes_TA_june_2014.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">42. Duquesnoy RJ, Marrari M, Mulder A, da M. Sousa LCD, Da Silva AS, do Monte SJH.: First Report on the Antibody Verification of HLA-ABC Epitopes Recorded in the HLA Epitope Registry. <i>Tissue Antigens 83: 391-400, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U43_First_report_ab-ver_class_II_epitopes_HumImm.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">43. Duquesnoy RJ, Marrari M, Tambur A, da Mata Sousa LCD, Da Silva AS, do Monte SJH. First Report on the Antibody Verification of HLA-DR, HLA-DQ and HLA-DP Epitopes Recorded in the HLA Epitope Registry. <i>Human Immunology 75:1097-1103, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U44_CH53_Terasaki_Festschrift.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">44. Duquesnoy RJ: HLA epitope based matching for transplantation: the way to go!  Terasaki Festschrift, <i>Clinical Transplants 2013, Chapter 53, 441-451, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U45_Ab_ver_MICA_ep_IJI_pub.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">45. Duquesnoy RJ, Marrari M, Mostecki J, Da Silva AS, da Mata Sousa LCD, do Monte SJH. First Report on the Antibody Verification of MICA Epitopes Recorded in the HLA Epitope Registry, <i>Int J Immunogenetics, 41:370-377, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U46_Editorial_COOT190416.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">46. Duquesnoy RJ: Epitope based human leukocyte matching in transplantation(Editorial), <i>Curr Opin Organ Transplantation,19,418-419 , 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U47_Ep_Ag-Im_COOT_190412.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">47. Duquesnoy RJ: HLA Epitope Antigenicity and Immunogenicity, <i>Curr Opin Organ Transplantation, 19, 428-435, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U48_Ltr_to_Edit__AJT_2014.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">48. Duquesnoy RJ: HLA epitopes and tolerance induction protocols, (Letter to the Editor) <i>Amer J Transplantation, 14:2667, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U49_final_proof_AJT_13167_Rev3_EV.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">49. Duquesnoy RJ, Kamoun M, Baxter-Lowe LA, Woodle ES, Bray RA, Claas FHJ, Eckels DD, Friedewald JJ, Fuggle SV, Gebel HM,. Gerlach JA, Fung JJ, Middleton D, Shapiro R, Tambur AR, Taylor CJ, Tinckam K, Zeevi A:Personal Viewpoint: Should HLA Mismatch Acceptability for Sensitized Transplant Candidates Be Determined at the High-Resolution rather than the Antigen Level? <i>Am J Transplant. 15: 923-930, 2015</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U50_letter_to_AJTproof.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">50. Duquesnoy RJ, Gebel HM, Woodle ES, Nickerson P, Baxter-Lowe LA, Bray RA, Claas. FHJ, Eckels DD, Friedewald JJ, Fuggle SV, Gerlach JA, Fung JJ, Kamoun M, Middleton D, Shapiro R, Tambur AR, Taylor CJ, Tinckam K, Zeevi A: High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms, (Letter to the Editor) <i>Am J Transplant, 2015</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/U51_Final_Front_allo_Tx_32198_Duquesnoy_Author's_Proof.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">51. Duquesnoy RJ, Marrari M, Mulder A: Usefulness of the nonself-self algorithm of HLA epitope immunogenicity in the specificity analysis of monospecific antibodies induced during pregnancy, <i>Frontiers in Immunology,  Vol 6, May 2015</i></td>
                    </tr>
                    <!--<tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>-->
                    <tr>
                        <td><a href="/pdfs/rene/53PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">53. Duquesnoy, RJ: The Antibody Response to a HLA Mismatch:  Putting Together the Pieces of a Puzzle (editorial) Am J Transplantation,15:3019-20, 2015 </td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/54PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">54. Duquesnoy RJ, Hönger G, Hösli I, Marrari M and Schaub S: Detection of newly antibody-defined epitopes on HLA class I alleles reacting with antibodies induced during pregnancy. Int J Immunogenetics un 16. doi: 10.1111/iji.12280. [Epub ahead of print], 2016 </td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/55PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">55. Duquesnoy RJ, Honger G, Hosli I, Marrari M, Schaub S. Identification of epitopes on HLA-DRB alleles reacting with antibodies in sera from women sensitized during pregnancy. Hum Immunol. 77: 214-222, 2016 </td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/56PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">56. Duquesnoy RJ, Hönger G, Hösli I, Marrari M and Schaub S: Detection : Antibody-defined epitopes on HLA-DQ alleles reacting with antibodies induced during pregnancy and the design of a DQ epitope map, Human Immunology 77: 824-831, 2016 </td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/57PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">57. Duquesnoy R: The eplet load concept in clinical transplantation, 38:(Invited Editorial) Pediatric Transplantation,20:884-5, 2016 </td>
                    </tr>
                     <tr>
                        <td><a href="/pdfs/rene/58PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">58. Duquesnoy RJ:  Should epitope-based compatibility be used in the Kidney Allocation System?  Human Immunol, 78: 24-29, 2017</td>
                    </tr>
	                   <tr>
                        <td><a href="/pdfs/rene/59PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">59. Duquesnoy RJ: Reflections on HLA Epitope-Based Matching for Transplantation, Frontiers in Immunology, <a href="https://doi.org/10.3389/fimmu.2016.00469">DOI.org</a>, Nov 28, 2016 </td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/60-1PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">60.1 Duquesnoy RJ and Marrari, M: Technology Reports: Application of HLA Epitope-Based Matching in the Clinical Transplant Setting.  Part I:   Antibody Reactivity with Epitopes ASHI Quarterly and EFI Newsletter, 2016</td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/60-2PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">60.2 Duquesnoy RJ and Marrari, M: Technology Reports: Application of HLA Epitope-Based Matching in the Clinical Transplant Setting. Part II: Pre-Transplant Serum Analysis for Epitope-Specific Antibodies ASHI Quarterly and EFI Newsletter, 2016</td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/60-3PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">60.3 Duquesnoy RJ and Marrari, M: Technology Reports: Application of HLA Epitope-Based Matching in the Clinical Transplant Setting. Part III: Control of Antibody Responses to HLA Epitopes ASHI Quarterly and EFI Newsletter, 2016</td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/61PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">61. Duquesnoy RJ: Are we ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?  Invited Overview, Transplantation, 101:1755-1765, 2017</td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/62PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">62. Duquesnoy RJ and Marrari, M: Usefulness of the ElliPro Epitope Predictor Program in Defining the Repertoire of HLA-ABC Eplets. Human Immunology 78:481-488, 2017</td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/63PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">63. Duquesnoy RJ: Epitope-based HLA Matching for Transplantation: A Personal Perspective of Its Future (invited review), Curr Opin Organ Transplant 23: 488-492, 2018 </td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/64PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">64. Duquesnoy, RJ: The Holy Grail to Clinical Transplant Tolerance is Paved with HLA Epitopes. OBM Transplantation 2, issue 3  doi:10.21926/obm.transplant.1803018,  2018 </td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/65PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">65. Duquesnoy, R.J., Marrari, M., Marroquin, M.S., Borges, A.G. , da Mata Sousa,  L. C. D. , Socorro, A. ,do Monte, S. J. H.: Second update of the International Registry of HLA Epitopes.  I. The HLA-ABC epitope database, Hum Immunol doi: 10.1016/j.humimm.2018.11.007</td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/66PDF.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">66. Duquesnoy RJ and Marrari M: Interlocus HLA Class II Cross-reactivity: Design of a Repertoire of Eplets Shared between HLA-DR, -DQ and -DP Alleles Rejected by Human Immunology, September 2019</td>
                    </tr>
                    <!--<tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/rene/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></td>
                    </tr>-->
                </table>
            </div>
            <h2 class="block-header">
              <span>HLA Epitope-related Publications by Other Investigators</span>
            </h2><br>
            <div >
                <table class="table">
                    <tr>
                        <td><a href="/pdfs/other/q1loba2002.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">1. Lobashevsky, AL, Senkbeil RW, Shoaf JL, Stephenson AK, Skelton SB, Burke RM, Deierhoi MH, and Thomas JM: The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. <i>Human Immunology 63: 364-74, 2002</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q2dankers2004.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">2. Dankers MKA, Witvliet MD, Roelen DL, de Lange P, Korfage N, Persijn GG, Duquesnoy RJ, Doxiadis IIN and Claas FHJ: The Number of Amino Acid Triplet Differences between Patient and Donor is Predictive for the Antibody Reactivity Against Mismatched HLA Antigens, <i>Transplantation I28: 1236-1239, 2004<i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q3LauxDPepitopeMatchingPaper.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">3. Laux G, Mansmann U, Deufel A, et al. A new epitope-based HLA-DPB matching approach for cadaver kidney retransplants. <i>Transplantation 2003; 75:1527–1532</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q4claas2004.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">4. Claas FHJ, Witvliet MD, Duquesnoy RJ, Persijn GG and Doxiadis IIN: The Acceptable Mismatch Program as a Fast Tool to Transplant Highly Sensitised Patients Awaiting a Post-Mortal Kidney: Short Waiting Time and Excellent Graft Outcome, <i>Transplantation 78: 190-193, 2004</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q5bho2004.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">5. Boehringer D, Reinhard T, Duquesnoy R , Boehringer S, Enczmann J, de  Lange  P, Claas F,  and Sundmacher R : Beneficial Effect of Matching at the HLA-A and B Amino-Acid Triplet Level on Rejection Free Survival in Penetrating Keratoplasty, <i>Transplantation 77: 417-421, 2004</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q6in2004.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">6. Iniotaki-Theodoraki A, Kalogeropoulou E, Apostolaki M, Doxiadis I, and Stavropoulos-Giokas C: Humoral sensitization against rejected grafts: Specific antibodies to graft immunogenic amino acid triplets. <i>Transplant Proc. 36: 1728-1731, 2004<i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q7var2004.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">7. Varnavidou-Nicolaidou, A, Doxiadis I, Iniotaki-Theodoraki A, Patargias T, Stavropoulos-Giokas C, and Kyriakides G: HLA class I donor-specific triplet antibodies detected after renal transplantation. <i>Transplantation Proceedings 36: 1732-1734, 2004</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q8Laundyabspecifaaresidues.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">8. Laundy GJ,  B.A. Bradley, B.M. Rees, M. Younie, and J.M. Hows Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia, <i>Transfusion 44:814-825, 2004</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q9YoungHLA_DP_AlloAb.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">9. Young D: HLA-DP antibodies. <i>ASHI Quarterly 2004 p60-62</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q10lau2004.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">10. Laux, G, Mytilineos J, and Opelz G: Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplanation. <i>Transplantation 77: 902-907, 2004</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q11dankers2004.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">11. Dankers MK, Heemskerk MB, Duquesnoy RJ, Doxiadis II, Oudshoorn M, Roelen DL and Claas FH: HLAMatchmaker algorithm is not a suitable tool to predict the alloreactive cytotoxic T-lymphocyte response in vitro. <i>Transplantation 78:165-7, 2004</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q12Takemoto.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">12. Takemoto S, Port FK, Claas FHJ and Duquesnoy RJ: HLA Matching for Kidney Transplantation, <i>Human Immunology 65: 1489-1505, 2004</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q13claas2005.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">13. Claas FHJ, Dankers MK, Oudshoorn M, van Rood JJ, Mulder A, Roelen DJ, Duquesnoy RJ and Doxiadis IIN: Differential Immunogenicity of HLA Mismatches in Clinical Transplantation. <i>Transplant Immunology 14: 187-191, 2005</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q14doxiadis2005.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">14. Doxiadis IIN, Duquesnoy, RJ, and Claas, FHJ: Extending options for highly sensitized patients to receive a suitable kidney graft. <i>Curr. Opin. Immunol. 17: 536-540, 2005</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q15Mulder2005peptideandHLAab.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">15. Mulder M, Eijsink C, Kester MGD, Franke MEI, Kardol MJ, Heemskerk MHM, et al. Impact of Peptides on the Recognition of HLA Class I Molecules by Human HLA Antibodies. <i>J Immunol 2005;175:5950–7</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q16HulsmeyrerJBC280page2972y2005.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">16. Hulsmeyer M, Chames P, Hillig R, Stanfield R, Held G, Coulie P, et al. A Major Histocompatibility Complex-Peptide-restricted antibody and T Cell Receptor molecules recognize their Target by distinct binding modes.  Crystal structure of Human Leukocyte Antigen (HLA)-A1 -MAGE-A1 complex with Fab-Hyb3, <i>J Biol Chem. 2005;280:2972-80</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q17nam2006.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">17. Nambiar A, Duquesnoy RJ, Adams S, Zhao Y, Oblitas J, Leitman S, Stroncek D and Marincola F: HLAMatchmaker-Driven Analysis Of Response To HLA Typed Platelet Transfusions In Alloimmunized Patients, <i>Blood 107: 1690-1697, 2006</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q18haririan2006.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">18. Haririan A, Fagoaga O, Daneshvar H, Morawski K, Sillix D, El-Amm J, West M, Garnick J, Migdal S, Gruber S, and Nehlsen-Cannarella S: Predictive value of HLA epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort. <i>Clinical Transplantation 20: 226-233 2006</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q19CaiDRantibodiesterasaki2006AJTx.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">19. Cai J, P. I. Terasaki, Q. Mao, T. Pham, N. El-Awar, J.-H. Lee and L. Rebellato: Development of Nondonor-Specific HLA-DR Antibodies in Allograft Recipients Is Associated with Shared Epitopes with Mismatched Donor DR Antigens, <i>Amer J Transplant 2006; 6: 2947–2954</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q20ros2006.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">20. Rosenberg, J, Berri R, Jackowski M, Levis D, Nehlsen-Cannarella S, and Oh H: Multi-array antibody screening in detecting antibodies to mismatched HLA in patients awaiting a second transplant. <i>Transplantation Proceedings 38: 3393-3395, 2006</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q21miha2006.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">21. Mihaylova, A, Baltadjieva D, Boneva P, Ivanova M, Penkova K, Marinova D, Mihailova S, Paskalev E, Simeonov P, and Naumova E: Clinical Relevance of Anti-HLA Antibodies Detected by Flow-Cytometry Bead-Based Assays—Single-Center Experience. <i>Human Immunology 67: 787–794, 2006</i></td>
                    </tr>
                    <tr>
                        <td><br></td>
                        <td align="left">22. El-Awar N, Terasaki PI, Cai J, Deng CT, Ozawa M, Nguyen A, et al. Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens. <i>Clinical Transplants. 2007:175-94</i></td>
                    </tr>
                    <tr>
                        <td><br></td>
                        <td align="left">23. Tambur AR, Buckingham M, McDonald L, Luo X. Development of donor-specific and non-donor-specific HLA-DP antibodies post-transplant: the role of epitope sharing and epitope matching. <i>Clinical Transplants. 2006:399-404.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q24good2006.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">24. Goodman, RS, Taylor C, O’Rourke C, Lynch A, Bradley JA, and Key T: Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitised patients awaiting kidney transplantation. <i>Transplantation 81: 1331-1336, 2006</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q25elAwarclassIbindingHUmimm2007.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">25. El-Awar N, Lee JH, Tarsitani C, Terasaki PI, El-Awar N, Lee J-H, et al. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. <i>Human Immunology. 2007;68(3):170-80.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q26elawar103classIeps2007.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">26. El-Awar NR, Akaza T, Terasaki PI, Nguyen A. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus. <i>Transplantation. 2007;84(4):532-40.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q27Piazza.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">27. Piazza A, Poggi E, Ozzella G, Borrelli L, Monaco PI, Scornajenghi A, et al. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. <i>Transplantation. 2006;81(9):1298-305.</i></td>
                    </tr>
                    <tr>
                        <td><br></td>
                        <td align="left">28. Idica A, Sasaki N, Terasaki P, Idica A, Sasaki N, Terasaki P. HLA matching by amino acid/positions in double and triple combinations. <i>Clinical Transplants. 2006:123-38.</i></td>
                    </tr>
                    <tr>
                        <td><br></td>
                        <td align="left">29. Idica A, Sasaki N, Hardy S, Terasaki P, Idica A, Sasaki N, et al. Unexpected frequencies of HLA antibody specificities in the sera of pre-transplant kidney patients. <i>Clinical Transplants. 2006:161-70.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q30Bishara.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">30. Bishara A, Brautbar C, Zamir G, Eid A, Safadi R, Bishara A, et al. Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. <i>Human Immunology. 2005;66(11):1099-105.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q31valentini2007.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">31. Valentini, RP, Nehlsen-Cannarella SL, Gruber SA, Mattoo TK, West MS, Lang C, Imam AA: Intravenous immunoglubulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients. <i>Pediatr. Transplant. 11: 77-81, 2007</i></td>
                    </tr>
                    <tr>
                        <td><br></td>
                        <td align="left">32. Tambur AR, Ching P, Ramon D. Prediction of immunogenic epitopes--is it feasible? <i>Clinical Transplants. 2007:203-10</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q33bro2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">33. Brooks EG, MacPherson BR and Fung MK: Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions. <i>Transfusion 48: 2159-2165, 2008</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q34kos2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">34. Kosmoliaptsis V, Bradley JA, Sharples LD, Chaudhry A, Key T, Goodman RS, et al. Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. <i>Transplantation 2008;85(12):1817-25.</i></td>
                    </tr>
                    <tr>
                        <td><br></td>
                        <td align="left">35. Maruya E, Sasaki N, El-Awar N, Akaza T, Kitawaki J, Saji H, et al. Immunogenic HLA class I epitopes identified by humoral response to pregnancies. <i>Clinical Transplants. 2008:215-27.</i></td>
                    </tr>
                    <tr>
                        <td><br></td>
                        <td align="left">36. Deng C-T, Cai J, Ozawa M, El-Awar N. HLA class II DP epitopes. <i>Clinical Transplants. 2007:195-202 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q37DengDQepabsTx2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">37. Deng CT, El-Awar N, Ozawa M, Cai J, Lachmann N, Terasaki PI, et al. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients. <i>Transplantation. 2008;86(3):452-9</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q38NAumovahlamMinBulgaria2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">38. Naumova E, Panchev P, Simeonov PJ, Mihaylova A, Penkova K, Boneva P, Marinov D, Paskalev PE, Simeonov PL, Zlatev A: Organ Transplantation in Bulgaria.  <i>Cell Tissue Banking 9:337-342, 2008</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q39CaicurropImm2009.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">39. Cai J, Terasaki PI. Post-transplantation antibody monitoring and HLA antibody epitope identification. <i>Current Opinion in Immunology. 2008;20(5):602-6.<i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q40VaidaDPreactiveantibodyinazeromismatch.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">40. Vaidya S, B Hilson, S Sheldon, P Cano, M Fernandez-Vina: DP reactive antibody in a zero mismatch renal transplant pair. <i>Human Immunol 68: 947-949, 2007</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q41elawarnormalmalesHIJul2009.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">41. El-Awar N, Terasaki PI, Nguyen A, Sasaki N, Morales-Buenrostro LE, Saji H, et al. Epitopes of HLA antibodies found in sera of normal healthy males and cord blood. <i>Hum Immunol 70:844-853, 2009</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q42KamounHLA-AaminoacidpolymorphismsandDGFPNAS2008.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">42. Kamoun M, JH. Holmes, AK. Israni, JD. Kearns, V Teal, WP Yang, SE. Rosas, MM. Joffe, H Li, and  HI. Feldman: HLA-A amino acid polymorphism and delayed kidneyallograft function.  <i>PNAS (2008) 105:18883–18888</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q43Kosmoliaptsis_Transplantation2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">43. Kosmoliaptsis V, Chaudhry AN, Sharples LD, Halsall DJ, Dafforn TR, Bradley JA, et al. Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. <i>Transplantation. 2009;88(6):791-8</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q44Cano.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">44. Cano P, Fernandez-Vina M (2009) Two sequence dimorphisms of DPB1 define the immunologically serologic epitopes. <i>Hum Imm 70:836-843, 2009</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q45ZouStastnyMICAImmunogenetics2009.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">45. Zou Y, Qin Z, Silveus A, Fan Y, Stastny P. Polymorphisms of MICA recognized by human alloantibodies. <i>Immunogenetics. 2009;61(2):91-100. </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q46Claas-Dox.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">46. Claas FHJ, Rahmel A, Doxiadis IIN. Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. <i>Transplantation. 2009;88(4):447-52. </i></td>
                    </tr>
                    <tr>
                        <td><br></td>
                        <td align="left">47. El-Awar N, Terasaki M, Cai J, Deng CT, Ozawa M, Lias M, et al. Epitopes of HLA-A, B, C, DR, DQ, DP and MICA Antigens. <i>Clinical Transplants. 2009;2009:295-321.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q48Claas.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">48. Claas FHJ. Towards selective HLA mismatching in clinical transplantation. <i>Transplantation. 2009;88(6):760-1.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q49Muro.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">49. Muro M, Gonzalez-Soriano MJ, Salgado G, Lopez R, Boix F, Lopez M, et al. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation. <i>Human Immunology. 2010;71(9):857-60</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q50Mulder.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">50. Mulder A, Kardol MJ, Arn JS, Eijsink C, Franke MEI, Schreuder GMT, et al. Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation. <i>Molecular Immunology. 2010;47(4):809-15.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q51BillenE.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">51. Billen EVA, Christiaans MHL, Doxiadis IIN, Voorter CEM, van den Berg-Loonen EM. HLA-DP antibodies before and after renal transplantation. <i>Tissue Antigens. 2010;75(3):278-85.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q52Kosmoliaptsis_Predict_clII_2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">52. Kosmoliaptsis V, Sharples LD, Chaudhry AN, Halsall DJ, Bradley JA, Taylor CJ. Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. <i>Transplantation. 2011;91(2):183-90.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q53TamburDQabepitopepub.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">53. Tambur A, Leventhal JR, Friedewald J, Ramon D. The Complexity of Human Leukocyte Antigen (HLA)-DQ Antibodies and Its Effect on Virtual Crossmatching. <i>Transplantation. 2010;90:1117-24 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q54Ravindranath.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">54. Ravindranath MH, Taniguchi M, Chen CW, Ozawa M, Kaneku H, El-Awar N, et al. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. <i>Molecular Immunology. 2010;47(5):1121-31</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q55AllAwar10MonoAbsEpitopes.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">55. El-Awar NR, Terasaki PI, Nguyen A, Lias M, Conger N. New HLA class I epitopes defined by murine monoclonal antibodies. <i>Hum Immunol. 2010;71:456-61.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q56Kosmoliaptsis_Ltr_Transplantation_2009.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">56. Kosmoliaptsis V, JABradley, CJ. Taylor: Structural Limitations to the Mimetic HLA Epitope Hypothesis (Letter to Editor). <i>Transplantation  87:1263, 2009</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q57ThaunatabstoDPeps2009.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">57. Thaunat O, Hanf W, Dubois V, McGregor B, Perrat G, Chauvet C, et al. Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation. <i>Transplant Immunology. 2009;20(4):209-11.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q58SuarezMICAep2009.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">58. Suarez-Alvarez B, Alonso-Arias R, Bravo-Mendoza C, Lopez-Vazquez A, Ortega T, Baltar JM, et al. Identification of epitopes and immunodominant regions on the MICA protein defined by alloantibodies from kidney transplant patients. <i>Transplantation. 2009;88(3 Suppl):S68-77.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q59Kosmoliaptsis_HuImm_2010.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">59. Kosmoliaptsis V, Sharples LD, Chaudhry A, Johnson RJ, Fuggle SV, Halsall DJ, et al. HLA class I amino acid sequence-based matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation. <i>Human Immunology. 2010;71(9):851-6. </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q60Cox.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">60. Cox ST, Stephens HAF, Fernando R, Karasu A, Harber M, Howie AJ, et al. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. <i>Human Immunology. 2011;72(10):827-34 </i></td>
                    </tr>
                    <tr>
                        <td><br></td>
                        <td align="left">61. Sasaki N, El-Awar N, Idica A. Effect of amino acid mismatch in the UNOS dataset. <i>Clinical Transplants. 2011:299-309.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q62Poli.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">62. Poli F, Benazzi E, Innocente A, Nocco A, Cagni N, Gianatti A, et al. Heart transplantation with donor-specific antibodies directed toward denatured HLA-A02:01: a case report. <i>Human Immunology. 2011;72(11):1045-8.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q63Jacob.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">63. Jacob EK, De Goey SR, Gandhi MJ. Positive virtual crossmatch with negative flow crossmatch results in two cases. <i>Transplant Immunology. 2011;25(1):77-81.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q64CoxdissertationonMICA2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">64. Cox ST. The relevance and impact of MICA allele mismatching and MICA antibodies on renal transplantation outcome:<i> University College London (UCL); 2011.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q65boh2010.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">65. Böhringer D, Daub F, Schwartzkopff J, Maier P, Birnbaum F, Sundmacher R and Reinhard T: Operational post-keratopasty graft tolerance due to differential HLAMatchmaker matching. <i>Molecular Vision 16: 2362-2367, 2010 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q66Pai2010.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">66. Pai SC, Lo SC, Lin Tsai SJ, Chang JS, Lin DT, Lin KS and Lin LI: Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases. <i>Transfusion 50: 2318-2327, 2010 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q67sil2010.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">67. Silva E, Alba A, Castro A, Carrascal M, Buckel E, Aguiló J, Herzog C, Calabrán L, Morales J and Fierro JA: Evaluation of HLAMatchmaker compatibility as predictor of graft survival and presence of anti-HLA antibodies. <i>Transplantation Proc. 42: 266-269, 2010</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q68Clark2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">68. Clark B, N Marsden, K McKinley, A Lewington and C Newstead: Successful kidney transplantation with a well-matched donor despite a positive crossmatch; detection and management of sensitization secondary to an alternate allelic variant of ‘self’ HLA . <i>Nephrology Dialysis Transplantation Plus  4: 258–259, 2011</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q69Ravindranath-xrHLA-EmAb_MolImm2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">69. Ravindranath MH, Pham T, El-Awar N, Kaneku H, Terasaki PI. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies. <i>Molecular Immunology. 2011;48(4):423-30</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q70SousaEpHLApublicationTxImm2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">70. Sousa LCDM, Sales HLA, Von Glehn C, Silva AS, Santos Neto PA, Castro JAF, et al. EpHLA: An innovative and user-friendly software automating the HLAMatchmaker algorithm for antibody analysis. <i>Transplant Immunol. 2011;25:210-6.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q71Kosmoliaptsis_HuImm_Nov2011.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">71. Kosmoliaptsis V, Dafforn TR, Chaudhry AN, Halsall DJ, Bradley JA, Taylor CJ. High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. <i>Human Immunology. 2011;72(11):1049-59.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q72ZielinskaPolandHLAMM.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">72. Zielinska H, G. Moszkowska, M. Zielinski, A. Debska-Slizien , B. Rutkowski, and P. Trzonkowski: Algorithm to Manage Highly Sensitized Kidney Transplant Recipients in Poland. <i>Transplant Proceed.  443:2903-2907, 2011 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q73tambur2010.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">73. Tambur A, Leventhal JR, Friedewald J and Ramon D: The complexity of human leukocyte antigen (HLA)-DQ antibodies and its effect on virtual crossmatching. <i>Transplantation 90: 1117-11124, 2010</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q74SalesEpHLAsoftware.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">74. Sales HLA, LC Demes da Mata Sousa, CQC von Glehn, AS da Silva, PA dos Santos Neto, FF do Nascimento, JAF de Castro, LM do Nascimento, C Kneib, HB Cazarote, DM Kitamura, JRD Torres, L da Cruz Lopes, AAL do Barros, EN da Silva Edlin, FSL de Moura, JMF Watanabe, SJH do Monte.  EpHLA software: A timesaving and accurate tool for improving identification of acceptable mismatches for clinical purposes. <i>Transplant Immunology 26: 230-234, 2012</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q75CallenderDPabnewCREGZachary2011HI.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">75. Callender CJ, M Fernandez-Vina, MS Leffell, AAZachary:Frequency of HLA-DP-specific antibodies and a possible new cross-reacting group. <i>Hum Immunol 73:175-179, 2012</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q76Bosch2012.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">76. Bosch A, S Llorente, JA Diaz, G Salgado, M LÔpez, F  Boix, R LÔpez-HernÂndez, MJ. GonzÂlez-Soriano, JA. Campillo, MR Moya-Quilesa, N Perez-Lopez, A Minguela, L Jimeno, MRA lvarez-LÔpez, M Muro: Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation. <i>Human Immunol. 73:522-525, 2012 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q77Kneibabtografts2012TA.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">77. Kneib C, von Glehn CQC, Costa FDA, Costa MTBA, Susin MF. Evaluation of humoral immune response to donor HLA after implantation of cellularized versus decellularized human heart valve allografts. <i>Tissue Antigens. 2012;80(2):165-74.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q78Israeli2013IntJimm.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">78. Israeli M, Sredni B, Mor E, Zakai C, Tadmor B, Klein T. The immune-modulator AS101 reduces anti-HLA antibodies in sera of sensitized patients: a structural approach. <i>International Immunopharmacology. 2012;13(4):483-9.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q79Ferrari.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">79. Ferrari-Lacraz S, Tiercy JM, Villard J. Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe? <i>Tissue Antigens. 2012;79(5):315-25.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q80Tambur-DQBbarrier-2012.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">80. Tambur AR, Leventhal JR, Zitzner JR, Walsh RC, Friedewald JJ. The DQ barrier: improving organ allocation equity using HLA-DQ information. <i>Transplantation. 2013;95(4):635-40. </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q81otten2013HLAepitopepresentedbyDR.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">81. Otten HG, Calis JJ, Kesmir C, van Zuilen AD, Spierings E. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation. <i>Hum.Immunol. 2013;74(3):290-296. </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q82ResseHLAMmclassIIeplets2013HI.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">82. Resse M, Paolillo R, Casamassimi A, Cavalca F, Fiorito C, Maiello C, et al. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant. <i>Hum Immunol. 2013;74:937–41.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q83HollenbachDPB-DPAEpitope2012.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">83. Hollenbach JA, Madbouly A, Gragert L, Vierra-Green C,  Flesch S, Spellman S, et al. A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer. <i>Immunogenetics. 2012;64(8):559-69.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q84MageeBloodTransfusionTx.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">84. Magee BA, Martin J, Cole MP, Morris KG, and Courtney AE: Effects of HLA-matched blood transfusion for patients awaiting renal transplantation.  <i>Transplantation 94:1111-1116, 2012.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q85EL-AwarDQepsinHIsep2013.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">85. El-Awar N, Nguyen A, Almeshari K, Alawami M, Alzayer F, Alharbi M, et al. HLA class II DQA and DQB epitopes: Recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines. <i>Human Immunology. 2013;74:1141-52. </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q86Schaubajt12048.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">86. Honger G, Fornaro I, Granado C, Tiercy JM, Hosli I, Schaub S. Frequency and determinants of pregnancy-induced child-specific sensitization. <i>American Journal of Transplantation. 2013;13(3):746-53.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q87MikkelsenDQA.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">87. Mikkelsen S, T. Korsholm, A. Iburg, M.S. Petersen, and B.K. Møller. Case Report: Binding of a Clinically Relevant Human Leukocyte Antigen–DQalpha–Specific Antibody in a Kidney Graft Recipient is Inhibited by Donor-Type Human Leukocyte Antigen–DQbeta Chain. <i>Transplant Proceed 45:1209-12, 2013.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q88wiebe2013.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">88. Wiebe C, Pochinco D, Blydt-Hansen TD, et al Class II HLA Epitope Matching—A Strategy to Minimize De Novo Donor-Specific Antibody Development and Improve Outcomes. <i>Am J Transplant. 2013;13:3114–22.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q89LutzBW4ab.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">89. Lutz CT, Al-Attar A, May JR, Jennings CD. Alloantibody to a Bw4 Epitope in a Bw4+ B27:05 Patient. Transplantation. 98: 852-856, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q90TamburDQeptx.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">90. Tambur A, Rosati J, Roitberg R, Glotz D, Friedewald JJ, Leventhal JR. Epitope analysis of HLA-DQ antigens: what does the antibody see? <i>Transplantation. 2014;98:157-66.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q91Mierze2014.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">91. Mierzejewska B, Schroder P, Caitlin, Baum C et al :  Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP <i>Human Immunology 75:703-708, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q92LutzBw4CurOpTx2014.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">92. Lutz CT: Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.  <i>Curr Opin Organ Transplant 19:436-441, 2014.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q93WiebeCurOpTx2014.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">93. Wiebe C, Nickerson P. Acceptable mismatching at the class II epitope level: the Canadian experience. <i>Curr Opin Organ Transplant. 19:442–6, 2014. </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q94MallonKosmoilaCurrOptx2014.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">94. Mallon D, Kosmoliaptsis V, Peacock S, Bradley JA, Taylor CJ. Structural and electrostatic analysis of HLA B-cell epitopes: Inference on immunogenicity and prediction of humoral alloresponses. <i>Curr Opin Organ Transplant. 19:420–7, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q95Salcido-OchoaHLAFSO2015.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">95. Salcido-Ochoa F: Human Leucocyte Antigen (HLA) System in Solid Organ Transplantation and Few Novel Concepts on HLA Matching. Recent Trends in Immunology (Editor: Shabir Ahmad Mir Published by <i>SM Online Publishers LLC <a href="http://www.smgebooks.com" target=_blank>www.smgebooks.com</a> 2015.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q96HutchinsonHLA_Typing.Tx2015.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">96. Hutchinson JA: HLA typing. <i>Transplantation 99:6-7, 2015</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q97Mongkolsuksharedeplet.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">97. Mongkolsuk T, A. Ingsathit, S. Worawichawong, S. Jirasiritham, P. Kitpoka, and D. Thammanichanond: Shared Molecular Eplet Stimulates Acute Antibody-Mediated Rejection in a Kidney Transplant Recipient With Low-Level Donor-Specific Antibodies: A Case Report. <i>Transplant Proceed 46:644-647, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q98Hwang.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">98. Hwang SD, MH Lee, BH Chung, Y Kim, K Han, CW Yang, EJ Oh: Complement-binding donor epitope sharing antibodies in a kidney transplant recipient : <i>Blood Transfusion 2015; 13: 161-3 </i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q99mallon2015.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">99. Mallon DH, Bradley JA, Winn PJ, Taylor CJ, Kosmoliaptsis V: Three-Dimensional Structural Modelling and Calculation of Electrostatic Potentials of HLA Bw4 and Bw6 Epitopes to Explain the Molecular Basis for Alloantibody Binding: Toward Predicting HLA Antigenicity and Immunogenicity <i>Transplantation 99:385-390, 2015.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q100HahnTxIm2015.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">100. Hahn AB, Bravo-Egana V, Jackstadt JL, Conti DJ and R.J.Duquesnoy:  HLA-A2 reactive antibodies in a patient who types as HLA-A2: The importance of high resolution typing and epitope-based antibody analysis, <i>Transplant Immunol 32:141-143, 2015.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q101sapirpaperajt12968.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">101. Sapir-Pichhadze R, K. Tinckam, K. Quach, A.G. Logan, A. Laupacis,R. John, J. Beyene, S.J. Kim: HLA-DR and -DQ Eplet Mismatches and Transplant . Glomerulopathy: A Nested Case–Control Study. <i>Amer J Transplant 2015; 15: 137–148.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q102Verdulin.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">102. Verduin EP, Schonewille H, Brand A, Haasnoot GW, Claas FHJ, Lindenburg ITM, et al. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation. <i>Transfusion. 2013;53(5):939-47.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q103Tambur.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">103. Tambur AR, Claas FH: HLA Epitopes as Viewed by Antibodies: What Is it All About? <i>Amer J Transplant 15:1148-1154, 2015.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q104geneugelijkJImmRes2014.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">104. Geneugelijk K, Thus KA, Spierings E. Review article: Predicting alloreactivity in transplantation. J. Immunol.Res. 2014; <i>article ID 159479.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q105ThusK.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">105. Thus KA, Ruizendaal MT, de Hoop TA, Borst E, van Deutekom HW, Te Boome L, et al. Refinement of the Definition of Permissible HLA-DPB1 Mismatches with Predicted Indirectly ReCognizable HLADPB1 Epitopes. <i>Biol.Blood Marrow Transplant. 2014;20(11):1705-1710.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q106Thus.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">106. Thus KA, Te Boome L, Kuball J, Spierings E. Indirectly Recognized HLA-C Mismatches and Their Potential Role in Transplant Outcome. <i>Front.Immunol. 2014;5:210.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q107Lowe.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">107. Lowe D, Shabir S, Buckels J, Muiesan P, Hayden G, Holt A, et al. HLA incompatible combined liver-kidney transplantation: dynamics of antibody modulation revealed by a novel approach to HLA antibody characterisation. <i>Transplant Immunology. 2014;30(1):30-3.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q108vanessenHLAMminCornealtx.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">108. van Essen TH , Roelen DL, Williams KA  and Jager MJ: Matching for Human Leukocyte Antigens (HLA) in corneal transplantation-To do or not to do. <i>Progr Retinal Eye Res46 (2015) 84-110.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q109nguyenHLAMMmodelling.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">109. Nguyen HD, G Wong, K Howard, FHJ Claas, JC Craig, S Fidler, L D’Orsogna, JR Chapman, A Irish, P Ferrari, FT Christiansen, WH Lim:  Modeling the Benefits and Costs of Integrating an Acceptable HLA Mismatch Allocation Model for Highly Sensitized Patients. <i>Transplantation 97:769-774, 2014</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q110middletonTpimmpaperDerek.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">110. Middleton D ,J Jones, D. Lowe. Review. Nothing's perfect: The art of defining HLA-specific antibodies. <i>Transplant Immunol. Xxx 2014.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q111Lashley.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">111. Lashley LO, van der Hoorn M-LP, Haasnoot GW, Roelen DL, Claas FHJ. Uncomplicated oocyte donation pregnancies are associated with a higher incidence of human leukocyte antigen alloantibodies. <i>Human Immunology. 2014;75(6):555-60.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q112Haarberg.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">112. Haarberg KMK, Tambur AR. Detection of donor-specific antibodies in kidney transplantation. <i>British Medical Bulletin. 2014;110(1):23-34.</i></td>
                    </tr>
                    <tr>
                        <td><a href="/pdfs/other/q113FilipponeClinTranspl2015.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left">113.  Filippone EJ, Farber JL. Humoral immunity in renal transplantation: epitopes, Cw and DP, and complement-activating capability – an update. <i>Clin Transplant 29:287-287, 2015</i></td>
                    </tr>
                    <!--<tr>
                        <td><a href="/pdfs/other/.pdf" target=_blank><img src="/img/pdf.gif" width="18px" /></a></td>
                        <td align="left"></i></td>
                    </tr>-->
                </table>
            </div>                
          </div>
        </div>
      </section>

    </main>
    <!-- .content -->

    <!-- ***** HERE IS A FOOTER ***** -->
    <footer class="footer">
      <div class="footer-copyright">
        <span>Copyright Rene Duquesnoy 2015</span>
      </div>
    </footer>
    <!-- .footer -->

  </div>
  <!-- .wrapper -->


  <!-- ***** VIDEO MODAL ***** -->
  <div class="modal videoModal fade" id="videoModal" tabindex="-1" role="dialog" aria-hidden="true">
    <div class="modal-dialog modal-lg">
      <div class="modal-content">
        <div class="modal-body">
          <div class="embed-responsive embed-responsive-16by9">
            <iframe class="embed-responsive-item" src="http://player.vimeo.com/video/27408483?title=0&amp;byline=0&amp;portrait=0&amp;color=ffffff"></iframe>
          </div>
        </div>
      </div>
    </div>
  </div>

  <!-- ***** SIGN UP MODAL ***** -->
  <div class="modal fade" id="signUp" tabindex="-1" role="dialog" aria-hidden="true" style="display: none;">
    <div class="modal-dialog modal-dialog-center form-dialog">
      <div class="modal-content text-center">
        <!--<div class="modal-header" style="background-image: url(img/parallax-bg.jpg)">
          Flexy
        </div>-->
        <div class="modal-body">
          <h3>HLAMatchmaker<span> registration</span></h3>
          <span class="subtitle">Free...no spam either!</span>

          <form method="post" class="contact-form form-validate3">

            <div class="form-group">
              <input class="form-control input-lg" type="text" name="name" id="name" placeholder="Name" required autocomplete="off">
            </div>

            <div class="form-group">
              <input class="form-control input-lg" type="email" name="email" placeholder="E-mail" required autocomplete="off">
            </div>

            <div class="form-group">
              <input type="password" name="pass" class="form-control" placeholder="Password" required autocomplete="off">
            </div>

            <input class="btn btn-md btn-primary btn-center" type="submit" value="Sign Up">
          </form>
        </div>
      </div>
      <!-- /.modal-content -->
    </div>
    <!-- /.modal-dialog -->
  </div>

  <!-- ***** LOGIN MODAL ***** -->
  <div class="modal fade" id="login" tabindex="-1" role="dialog" aria-hidden="true" style="display: none;">
    <div class="modal-dialog modal-dialog-center form-dialog">
      <div class="modal-content text-center">
        <!--<div class="modal-header" style="background-image: url(img/parallax-bg.jpg)">
          Flexy
        </div>-->
        <div class="modal-body">
          <h3>Login and Get <span>Started</span></h3>
          <span class="subtitle">Get access to the downloads!</span>

          <form method="post" class="contact-form form-validate4">

            <div class="form-group">
              <input class="form-control input-lg" type="email" name="email" placeholder="E-mail" required autocomplete="off">
            </div>

            <div class="form-group">
              <input type="password" name="pass" class="form-control" placeholder="Password" required autocomplete="off">
            </div>

            <input class="btn btn-md btn-primary btn-center" type="submit" value="Login">
          </form>
        </div>
      </div>
      <!-- /.modal-content -->
    </div>
    <!-- /.modal-dialog -->
  </div>




  <!-- *********** ALL JS PLUGINS AND LIBRARIES ************* -->

  <!-- Jquery lib -->
  <script src="js/libs/jquery-1.11.1.min.js"></script>

  <!-- Bootstrap js -->
  <script src="js/plugins/bootstrap.min.js"></script>

  <!-- Parallax -->
  <script src="js/plugins/jquery.stellar.min.js"></script>

  <!-- Page smooth scroll -->
  <script src="js/plugins/smoothscroll.js"></script>

  <!-- Lightbox plugin -->
  <script src="js/plugins/jquery.prettyPhoto.min.js"></script>

  <!-- Waypoint plugin -->
  <script src="js/plugins/waypoints.min.js"></script>

  <!-- Numbers animate plugin -->
  <script src="js/plugins/jquery-numerator.min.js"></script>

  <!-- Circle progress bar plugin -->
  <script src="js/plugins/jquery.circliful.min.js"></script>

  <!-- Parallax plugin -->
  <script src="js/plugins/owl.carousel.min.js"></script>

  <!-- Auto typing text -->
  <script src="js/plugins/typed.min.js"></script>

  <!-- Map api -->
  <script src="https://maps.googleapis.com/maps/api/js?sensor=false"></script>

  <!-- Custom checkbox & radio plugin -->
  <script src="js/plugins/icheck.min.js"></script>

  <!-- Countdown -->
  <script src="js/plugins/jquery.countdown.min.js"></script>

  <!-- Form validate plug -->
  <script src="js/plugins/jquery.validate.min.js"></script>

  <!-- Form validate plug -->
  <script src="mailer/mailer.js"></script>


  <!-- Custom js with all initialisation and plugin settings -->
  <script src="js/custom.js"></script>
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-66616709-1', 'auto');
  ga('send', 'pageview');

</script>
</body>

</html>
